20.93USD-4.82%Mkt Cap: 2.36B USDP/E: —Last update: 2026-06-01
Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company d…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap2.36B USD
Enterprise Value1.89B USD
Revenue (TTM)4.01M USD
Gross Profit-182.78M USD
Net Income (TTM)-212.39M USD
Revenue/Share0.0420 USD
Last Price20.93 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees206
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.54
PEG—
EV/EBITDA-8.36
EV/Revenue471.55
P/S615.75
P/B4.20
EPS (TTM)-2.39
EPS (Forward)-2.07
52W Range
7.96066% of range27.65
52W High27.65 USD
52W Low7.960 USD
Profitability
Gross Margin0.00%
Oper. Margin-5698.83%
EBITDA Margin0.00%
Profit Margin-3059.99%
ROE-33.48%
ROA-31.09%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-190.92M USD
CapEx (TTM)15.93M USD
FCF Margin-3469.81%
FCF Yield-5.90%
Net Debt-579.00M USD
Net Debt/EBITDA2.56
Balance Sheet
Debt/Equity0.01
Current Ratio21.68
Quick Ratio21.26
Book Value/Sh5.202 USD
Cash/Share5.145 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)35.36 USD
Target Range30.00 USD – 40.00 USD
# Analysts14
Ownership
Shares Out.113.25M
Float108.33M
Insiders6.30%
Institutions108.36%
Short Interest
Short Ratio20.7d
Short % Float18.21%
Short % Out.15.57%
Shares Short17.63M
Short (prev mo.)18.60M
Technical
SMA 5022.11 (-5.3%)
SMA 20018.66 (+12.2%)
Beta2.12
S&P 52W Chg27.94%
Avg Vol (30d)897.70K
Avg Vol (10d)1.11M
Technical Indicators
RSI (14)49.0
MACD-0.1539
MACD Signal-0.2086
MACD Hist.+0.0547
BB Upper24.14 USD
BB Middle22.11 USD
BB Lower20.08 USD
BB Width18.33%
ATR (14)1.195 USD
Vol Ratio (20d)0.45x